IMPAX Laboratories, Inc. (Impax) is a publicly traded technology based specialty pharmaceutical company. It is engaged in the development and commercialization of bioequivalent, generic and branded pharmaceuticals. The company develops its pharmaceuticals with the help of controlled release, development and formulation expertise. Its branded products are used in the treatment of disorders related to the central nervous system. The company focuses on controlled release generic versions of a few branded pharmaceuticals to target a range of therapeutic areas. Impax operates its business in two segments, namely, Impax Pharmaceutical and Global Pharmaceuticals. IMPAX is headquartered at Hayward in California, the US.